-
iRadimed Corporation (IRMD $56.69)
- $56.69 Fwd P/E: 36.57X Cap: $720M
- View IRMD Profile
- View Questions on IRMD
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
iRadimed Corporation (IRMD $56.69)
- $56.69 Fwd P/E: 36.57X Cap: $720M
- View IRMD Profile
- View Questions on IRMD
Q: Let me be the first to ask you about this company.
Main product appears to be a monopoly with no competition. They are releasing an updated version soon, with a good chunk of their installed base nearing EOL and due for replacement.
Founder led. No debt, net cash. High returns on capital, growing nicely. Secular tale winds in healthcare space. Valuation doesn't seem stretched.
Outside of being smaller in size, any red flags for you? On first glance, is it something you'd personally consider investing in?
Thanks.
Main product appears to be a monopoly with no competition. They are releasing an updated version soon, with a good chunk of their installed base nearing EOL and due for replacement.
Founder led. No debt, net cash. High returns on capital, growing nicely. Secular tale winds in healthcare space. Valuation doesn't seem stretched.
Outside of being smaller in size, any red flags for you? On first glance, is it something you'd personally consider investing in?
Thanks.
Insiders
Share Information
SEC Filings
News and Media